삼아제약

009300KOSDAQ

58.0 / 100

Reference Date: 2026-09-08

Financial Score27.5 / 40

News Sentiment12.5 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Rose 6.6% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Samah Pharmaceutical is a pharmaceutical company specializing in the production and sale of respiratory, dermatological, and analgesic drugs, along with health functional foods. It operates a state-of-the-art production facility established in 2009 at the Munmak plant. However, revenue declined by 18.6% year-on-year in 2023 due to a decrease in respiratory patients, with respiratory drugs (67.7%) and analgesics (13.2%) contributing the majority of sales.

Number of Employees

310people

Average Salary

56.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

6.55Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR

0.39Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

5.78Industry Average 8.002.5Point

Below industry avg

Debt Ratio

2.21Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼10.1% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼25.5% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 9.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (33%)

Current 13,890Won52-week high 17,45052-week low 12,130

1-month return4.0Point

1m +6.60% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-13